Application

17814704 · MITIGATION AND REVERSAL OF INTESTINAL FIBROSIS AND INFLAMMATION BY INHIBITION OF TL1A FUNCTION

Filed 2022-07-25 · Granted · Patent 12590160 (2026-03-31) The official file ↗The patent and its PDF ↗ · Art unit 1674 · Examiner Claire M Kaufman Typical · CPC A61P 1/00 · CEDARS-SINAI MEDICAL CENTER · Jones Day for Merck-PBI-CSMC

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

18.0 mo

to disposition 44.2 mo

Statutes raised

102 103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.